Back to search

Article

Efficacy and safety of tofacitinib in treatment of pemphigus: a single-center cohort study

2025-03-11

Abstract excerpt

<title>Abstract</title> <p>To evaluate the efficacy, safety, and steroid-sparing effect of tofacitinib combined with corticosteroids (CS) in pemphigus treatment. Clinical data from moderate pemphigus patients treated with CS monotherapy or CS plus tofacitinib (CT) between June 2019 and January 2024 were analyzed. The primary endpoint was complete remission (CR) rate at 1 year. Secondary endpoints comprised the mo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b69d269f-934d-5f2c-9eab-d436a3a5d915
DOI
10.21203/rs.3.rs-6138704/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and safety of tofacitinib in treatment of pemphigus: a single-center cohort studyDOI 10.21203/rs.3.rs-6138704/v1
Select a neighboring publication to make it the new centre.